BSX Q1 2026 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Wed, April 22, 2026 astatine 10:07 AM CDT 44 min read

Image source: The Motley Fool.

Wednesday, April 22, 2026 astatine 8:00 a.m. ET

• Chairman and Chief Executive Officer — Michael Mahoney

• Executive Vice President and Chief Financial Officer — Jonathan Monson

• Chief Medical Officer — Ken Stein

• Vice President, Investor Relations — Lauren Tengler

Lauren Tengler: Thank you, Bailey, and acknowledgment to everyone for joining us. With maine contiguous are Mike Mahoney, Chairman and Chief Executive Officer; Jon Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and John volition beryllium joined by our Chief Medical Officer, Dr. Ken Stein. We issued a property merchandise earlier this greeting announcing our Q1 2026 results, which included reconciliations of the non-GAAP measures utilized successful this release. The merchandise arsenic good arsenic reconciliations of non-GAAP measures utilized successful today's telephone tin beryllium recovered connected the Investor Relations conception of the website.

Please enactment that connected the call, operational gross excludes the interaction of overseas currency fluctuations, and integrated gross further excludes definite acquisitions and divestitures for which determination is little than a afloat play of comparable nett sales. Guidance excludes the antecedently announced statement to get Penumbra, which is expected to adjacent successful 2026, taxable to customary closing conditions. For much information, delight notation to the Q1 fiscal and operating highlights deck, which whitethorn beryllium recovered successful the Investor Relations conception of our website. On this call, each references to income and gross are integrated and comparative maturation is compared to the aforesaid 4th successful anterior year, unless different specified.

This telephone contains forward-looking statements regarding, among different things, our fiscal performance, concern plans and merchandise show and development. These statements are based connected our existent beliefs utilizing accusation disposable to america arsenic of today's date. and are not intended to beryllium guarantees of aboriginal events oregon performance. If our underlying assumptions crook retired to beryllium incorrect oregon definite risks oregon uncertainties materialize, existent results could alteration materially from those projected by the forward-looking statements. Factors that whitethorn origin specified differences are discussed successful our periodic reports and different filings with the SEC, including the Risk Factors conception of our astir caller yearly study connected Form 10-K.

Boston Scientific disclaims immoderate volition oregon work to update these forward-looking statements, but arsenic required by law. In addition, this telephone does not represent an connection to merchantability oregon the solicitation of immoderate connection to bargain immoderate securities oregon solicitation of immoderate ballot oregon support successful transportation with the projected transaction with Penumbra. Boston Scientific has filed with the SEC a registration connection connected Form S-4 containing a proxy connection of Penumbra and a prospectus of Boston Scientific that contains important accusation astir Penumbra, Boston Scientific, the projected transaction and related matters. At this point, I'll crook it implicit to Mike.